It seems that making emergency contraception (EC) available over-the-counter (OTC) changes nothing except where such contraception is obtained.
It seems that making emergency contraception (EC) available over-the-counter (OTC) changes nothing except where such contraception is obtained.
The findings come from an analysis of an Omnibus Survey of 7,600 adults aged 16 to 49 years in Great Britain.
The survey revealed that levels of use of different types of contraception remained similar before and after emergency hormonal contraception went OTC. No significant changes occurred in the proportion of women using such contraception or in the proportion having unprotected sex. The only thing that did change is that a smaller proportion of the women obtained the EC from physicians and a greater percentage obtained it OTC.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More